Scientific Program - Wilson's disease

Print
Please see below the CONy Scientific Program. Please click on the appropriate section (ordered by ABC) to view the relevant program. Please note that the program and timing is subject to change. To view the program timetable, please click here
 
 
Section Head: Anna Czlonkowska, Poland
SATURDAY MARCH 24, 2018 HALL D
07:00-08:00
E-Poster Presentations
   
08:00-10:00
SESSION 35| WILSON'S DISEASE (WD): HISTORY, PRESENT, AND FUTURE
  Chairs: Adam Przybylkowski, Poland
08:00-08:20
Kinnier Wilson and Wilson's disease: Emmanuel Broussolle, France
08:20-08:40
The new Wilson’s like disease: treatable manganese metabolism disorders causing parkinsonism and dystonia: Antonio Federico, Italy
08:40-09:00
Acquired copper deficiency in patients with and without WD: France Woimant, France
09:00-09:20
China's experience: Clinic of WD: Xiaoping Wang, China
09:20-09:30
Brain atrophy and neurological impairment in Wilson`s disease: Lukasz Smolinski, Poland
09:30-09:40 Transcranial brain parenchyma sonography in Wilson`s disease and healthy controls: quantification and correlations with clinical parameters: G. G. Tribl, Brazil
09:40-09:50 Determination of copper poisoning in Wilson’s disease and other metal dysbalances using laser ablation inductively coupled plasma spectrometry (la-icp-ms): Ralf Weiskirchen, Germany
   
09:50-10:10 Coffee Break
   
10:10-12:10 SESSION 36| WD: PATHOGENESIS, EPIDEMIOLOGY, THERAPY
  Chairs: Carl Bjartmar, Sweden & Ermal Kurmaku, Albania
10:10-10:30
Introduction:
Anna Czlonkowska, Poland

Pathogenesis & Epidemiology
10:30-10:50
WD: pathogenesis, genetic and epigenetic factors: Valentina Medici, USA
10:50-11:10
Epidemiology – disease still underdiagnosed: Olivier Bandmann, UK
   

Clinical manifestations- great variability
11:10-11:30
The hepatic manifestations: Piotr Socha, Poland
11:30-11:50
The neurological manifestations: Petr Dusek, Czech Republic
11:50-12:10
Other organs: Karolina Dziezyc, Poland
   
12:10-13:10 Industry Sponsored Symposium (Not for CME) – Hall A
   
13:10-13:55 Lunch Break
   
13:55-15:15 SESSION 37| WD: TREATMENT
 Chairpersons:   Malgorzata Wiszniewska, Poland
 13:55-14:15 Current anti-copper therapy: Tomasz Litwin, Poland
14:15-14:35 We need more options: Karl Heinz Weiss, Germany
14:35-14:55
Is liver transplantation a reasonable alternative in patients resistant to chelators?Aurélia Poujois, France
14:55-15:15
Role of botulotoxin type a in the complex treatment of the hypokinesia in patients with Wilson disease: Sergey Lobzin, Russia
   
15:55-16:15 Coffee Break